Nova Mentis Life Science Corp. — Form D
Nova Mentis Life Science Corp. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-05. The offering totals $88K, of which $88K was reported sold. Industry: Other.
Offering
- Filed: 2018-02-05
- Form: D
- Accession: 0001085037-18-000018
- Industry: Other
- Exemptions: 06b
- Total offering: $88K
- Amount sold: $88K
- Investors: 6
- Date of first sale: 2018-01-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-304820
Issuer
- Name: Nova Mentis Life Science Corp.
- CIK: 0001689231
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 700-838 WEST HASTINGS STREET, VANCOUVER, A1, V6C 0A6
- Phone: 7788190244
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| KEITH ANDERSON | Director | BOSTON, MA |
| Doug Macdonell | Director | Vancouver, A1 |
| Kelly Pladson | Executive Officer | VANCOUVER, A1 |
| Steven Feldman | Director | Lynbrook, NY |
| Jamie Robinson | Executive Officer | GRAND CAYMAN, E9 |
| William Rascan | Director | Vancouver, A1 |
| William Rascan | Executive Officer | Vancouver, A1 |
| Dr. Aylia Mohammadi | Director | Vancouver, A1 |
Other filings by this issuer (2)
More